Aker BioMarine ASA (Public, OSL:AKBM) is a Norwegian fishing and seafood processing company. Based in Oslo, it operates three krill fishing vessels in Antartica, Argentina and the Faroe Islands.
Worldwide leader in Krill catching, procesing and marketing. The company is listed on the Oslo Stock Exchange, but controlled 83% by Aker Seafoods, controlled by the Aker Group.
Aker BioMarine has registered Superba™ as the company`s brandnames for its krill oil products for the human market and Qrill™ company’s brand name for its krill meal and krill oil products for aquaculture feed markets.
The Company has four wholly owned subsidiaries, including, Aker BioMarine Antarctic AS, Krill AS, Natural Nutrition Development AS and Natural USA Inc. Aker BioMarine ASA has also a 50% stake in O3C Nutraceuticals AS.
October 2012 - regarding the proposed merger between Aker BioMarine ASA ("AKBM"), the transferor company, and Aker Seafoods Holding AS ("AKSH") the transferee company, where the shareholders in AKBM (except AKSH) will receive consideration shares in Aker ASA ("AKER") (the "Merger"). AKBM has today, Friday 9 November 2012, held an extraordinary general meeting regarding the Merger. The proposal was approved by the general meeting.
Govt plans to limit Pacific bluefin tuna catch Japan
The Japanese Government intends to reduce the catch of immature Pacific bluefin tuna and prevent overfishing of the high-priced fish by implementing common regulations internationally, out of criteria currently adopted independently by Japan.